Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide vs Flixotide in Children with Asthma
NCT00197106Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salmeterol + fluticasone propionate in asthma (2 arms), sponsored by GSK. Primary endpoint: Percentage of Symptom-free Days During the Last 10 Weeks of the Treatment Period at 26 weeks. Started Jun 2005; status: completed.
02
Drugs
salmeterol + fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00197106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197106.